nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotaxime—SLC15A1—Lisinopril—dilated cardiomyopathy	0.329	0.381	CbGbCtD
Cefotaxime—SLC22A11—Furosemide—dilated cardiomyopathy	0.269	0.312	CbGbCtD
Cefotaxime—SLC22A8—Furosemide—dilated cardiomyopathy	0.156	0.181	CbGbCtD
Cefotaxime—SLC22A6—Furosemide—dilated cardiomyopathy	0.109	0.126	CbGbCtD
Cefotaxime—Bullous eruption—Furosemide—dilated cardiomyopathy	0.00624	0.0544	CcSEcCtD
Cefotaxime—Local reaction—Furosemide—dilated cardiomyopathy	0.00446	0.0388	CcSEcCtD
Cefotaxime—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00366	0.0318	CcSEcCtD
Cefotaxime—Cholestasis—Furosemide—dilated cardiomyopathy	0.00325	0.0283	CcSEcCtD
Cefotaxime—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00322	0.0281	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00297	0.0258	CcSEcCtD
Cefotaxime—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00282	0.0245	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00252	0.0219	CcSEcCtD
Cefotaxime—Renal failure—Spironolactone—dilated cardiomyopathy	0.00249	0.0217	CcSEcCtD
Cefotaxime—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00244	0.185	CbGpPWpGaD
Cefotaxime—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00237	0.0206	CcSEcCtD
Cefotaxime—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00232	0.0202	CcSEcCtD
Cefotaxime—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00221	0.168	CbGpPWpGaD
Cefotaxime—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00215	0.0188	CcSEcCtD
Cefotaxime—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00198	0.0173	CcSEcCtD
Cefotaxime—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00187	0.0163	CcSEcCtD
Cefotaxime—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00186	0.141	CbGpPWpGaD
Cefotaxime—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00184	0.016	CcSEcCtD
Cefotaxime—Malaise—Spironolactone—dilated cardiomyopathy	0.00179	0.0156	CcSEcCtD
Cefotaxime—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00178	0.0155	CcSEcCtD
Cefotaxime—Discomfort—Spironolactone—dilated cardiomyopathy	0.00167	0.0145	CcSEcCtD
Cefotaxime—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00162	0.0141	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00161	0.014	CcSEcCtD
Cefotaxime—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00158	0.0138	CcSEcCtD
Cefotaxime—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00155	0.118	CbGpPWpGaD
Cefotaxime—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00154	0.0134	CcSEcCtD
Cefotaxime—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00153	0.0133	CcSEcCtD
Cefotaxime—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00149	0.013	CcSEcCtD
Cefotaxime—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00141	0.0123	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00137	0.0119	CcSEcCtD
Cefotaxime—Renal failure—Furosemide—dilated cardiomyopathy	0.00136	0.0118	CcSEcCtD
Cefotaxime—Cephaloglycin—SLC22A5—dilated cardiomyopathy	0.00135	0.161	CrCbGaD
Cefotaxime—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00133	0.0116	CcSEcCtD
Cefotaxime—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00129	0.0112	CcSEcCtD
Cefotaxime—Urticaria—Spironolactone—dilated cardiomyopathy	0.00129	0.0112	CcSEcCtD
Cefotaxime—Cefepime—SLC22A5—dilated cardiomyopathy	0.00128	0.152	CrCbGaD
Cefotaxime—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00128	0.0111	CcSEcCtD
Cefotaxime—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00121	0.0105	CcSEcCtD
Cefotaxime—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00119	0.0104	CcSEcCtD
Cefotaxime—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00117	0.0102	CcSEcCtD
Cefotaxime—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00115	0.01	CcSEcCtD
Cefotaxime—Pruritus—Spironolactone—dilated cardiomyopathy	0.00115	0.00997	CcSEcCtD
Cefotaxime—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00114	0.00995	CcSEcCtD
Cefotaxime—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00111	0.00964	CcSEcCtD
Cefotaxime—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00111	0.00964	CcSEcCtD
Cefotaxime—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00109	0.00946	CcSEcCtD
Cefotaxime—Vomiting—Spironolactone—dilated cardiomyopathy	0.00103	0.00896	CcSEcCtD
Cefotaxime—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00103	0.00894	CcSEcCtD
Cefotaxime—Rash—Spironolactone—dilated cardiomyopathy	0.00102	0.00888	CcSEcCtD
Cefotaxime—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00102	0.00888	CcSEcCtD
Cefotaxime—Renal failure—Lisinopril—dilated cardiomyopathy	0.00102	0.00886	CcSEcCtD
Cefotaxime—Headache—Spironolactone—dilated cardiomyopathy	0.00101	0.00883	CcSEcCtD
Cefotaxime—Jaundice—Lisinopril—dilated cardiomyopathy	0.00101	0.00879	CcSEcCtD
Cefotaxime—Cefixime—SLC22A5—dilated cardiomyopathy	0.001	0.119	CrCbGaD
Cefotaxime—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000967	0.00842	CcSEcCtD
Cefotaxime—Leukopenia—Furosemide—dilated cardiomyopathy	0.000966	0.00841	CcSEcCtD
Cefotaxime—Nausea—Spironolactone—dilated cardiomyopathy	0.000961	0.00837	CcSEcCtD
Cefotaxime—Ceftazidime—SLC22A5—dilated cardiomyopathy	0.000943	0.112	CrCbGaD
Cefotaxime—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00093	0.0081	CcSEcCtD
Cefotaxime—Cefdinir—SLC22A5—dilated cardiomyopathy	0.000926	0.11	CrCbGaD
Cefotaxime—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000881	0.00767	CcSEcCtD
Cefotaxime—Cefradine—SLC22A5—dilated cardiomyopathy	0.000879	0.105	CrCbGaD
Cefotaxime—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000879	0.00765	CcSEcCtD
Cefotaxime—Shock—Furosemide—dilated cardiomyopathy	0.000866	0.00754	CcSEcCtD
Cefotaxime—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000862	0.00751	CcSEcCtD
Cefotaxime—Cefadroxil—SLC22A5—dilated cardiomyopathy	0.000832	0.0988	CrCbGaD
Cefotaxime—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000831	0.00723	CcSEcCtD
Cefotaxime—Pain—Furosemide—dilated cardiomyopathy	0.000753	0.00656	CcSEcCtD
Cefotaxime—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000751	0.00654	CcSEcCtD
Cefotaxime—Angioedema—Lisinopril—dilated cardiomyopathy	0.00074	0.00644	CcSEcCtD
Cefotaxime—Malaise—Lisinopril—dilated cardiomyopathy	0.00073	0.00636	CcSEcCtD
Cefotaxime—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000726	0.00632	CcSEcCtD
Cefotaxime—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000725	0.00631	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00072	0.00627	CcSEcCtD
Cefotaxime—Urticaria—Furosemide—dilated cardiomyopathy	0.0007	0.00609	CcSEcCtD
Cefotaxime—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000696	0.00606	CcSEcCtD
Cefotaxime—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000696	0.00606	CcSEcCtD
Cefotaxime—Discomfort—Lisinopril—dilated cardiomyopathy	0.000681	0.00593	CcSEcCtD
Cefotaxime—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000661	0.00575	CcSEcCtD
Cefotaxime—Shock—Lisinopril—dilated cardiomyopathy	0.00065	0.00566	CcSEcCtD
Cefotaxime—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000649	0.00565	CcSEcCtD
Cefotaxime—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000647	0.00563	CcSEcCtD
Cefotaxime—Cefalotin—SLC22A5—dilated cardiomyopathy	0.000626	0.0744	CrCbGaD
Cefotaxime—Pruritus—Furosemide—dilated cardiomyopathy	0.000623	0.00542	CcSEcCtD
Cefotaxime—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000602	0.00524	CcSEcCtD
Cefotaxime—Cephalexin—SLC22A5—dilated cardiomyopathy	0.000569	0.0676	CrCbGaD
Cefotaxime—Pain—Lisinopril—dilated cardiomyopathy	0.000565	0.00492	CcSEcCtD
Cefotaxime—Vomiting—Furosemide—dilated cardiomyopathy	0.00056	0.00487	CcSEcCtD
Cefotaxime—Rash—Furosemide—dilated cardiomyopathy	0.000555	0.00483	CcSEcCtD
Cefotaxime—Dermatitis—Furosemide—dilated cardiomyopathy	0.000555	0.00483	CcSEcCtD
Cefotaxime—Headache—Furosemide—dilated cardiomyopathy	0.000552	0.0048	CcSEcCtD
Cefotaxime—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000544	0.00474	CcSEcCtD
Cefotaxime—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00054	0.0047	CcSEcCtD
Cefotaxime—Urticaria—Lisinopril—dilated cardiomyopathy	0.000525	0.00457	CcSEcCtD
Cefotaxime—Nausea—Furosemide—dilated cardiomyopathy	0.000523	0.00455	CcSEcCtD
Cefotaxime—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000522	0.00455	CcSEcCtD
Cefotaxime—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000522	0.00455	CcSEcCtD
Cefotaxime—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000488	0.037	CbGpPWpGaD
Cefotaxime—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000487	0.00424	CcSEcCtD
Cefotaxime—Pruritus—Lisinopril—dilated cardiomyopathy	0.000467	0.00407	CcSEcCtD
Cefotaxime—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000452	0.00394	CcSEcCtD
Cefotaxime—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000443	0.0336	CbGpPWpGaD
Cefotaxime—Vomiting—Lisinopril—dilated cardiomyopathy	0.00042	0.00366	CcSEcCtD
Cefotaxime—Rash—Lisinopril—dilated cardiomyopathy	0.000417	0.00363	CcSEcCtD
Cefotaxime—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000416	0.00362	CcSEcCtD
Cefotaxime—Headache—Lisinopril—dilated cardiomyopathy	0.000414	0.0036	CcSEcCtD
Cefotaxime—Nausea—Lisinopril—dilated cardiomyopathy	0.000392	0.00342	CcSEcCtD
Cefotaxime—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000372	0.0282	CbGpPWpGaD
Cefotaxime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000311	0.0236	CbGpPWpGaD
Cefotaxime—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000222	0.0168	CbGpPWpGaD
Cefotaxime—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000205	0.0155	CbGpPWpGaD
Cefotaxime—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000201	0.0153	CbGpPWpGaD
Cefotaxime—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00019	0.0144	CbGpPWpGaD
Cefotaxime—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000169	0.0128	CbGpPWpGaD
Cefotaxime—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000141	0.0107	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000116	0.00879	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000113	0.00855	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000113	0.00855	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000107	0.00812	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000105	0.00797	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000105	0.00795	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000104	0.0079	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000104	0.0079	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000102	0.00776	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000102	0.00776	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.94e-05	0.00754	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.68e-05	0.00734	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.67e-05	0.00733	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.67e-05	0.00733	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.51e-05	0.00721	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.99e-05	0.00681	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.84e-05	0.0067	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.6e-05	0.00652	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.6e-05	0.00652	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.99e-05	0.00606	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.38e-05	0.00559	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.18e-05	0.00544	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.18e-05	0.00544	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.67e-05	0.00506	CbGpPWpGaD
Cefotaxime—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.29e-05	0.00173	CbGpPWpGaD
Cefotaxime—SLC15A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.11e-05	0.0016	CbGpPWpGaD
Cefotaxime—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.07e-05	0.00157	CbGpPWpGaD
Cefotaxime—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.96e-05	0.00149	CbGpPWpGaD
Cefotaxime—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.74e-05	0.00132	CbGpPWpGaD
Cefotaxime—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.46e-05	0.0011	CbGpPWpGaD
